Its product portfolio includes tafluprost/timolol maleate, a prostaglandin F2a derivative and a beta-adrenergic receptor blocker; and netarsudil mesilate and latanoprost, a prostaglandin F2a ...

智通财经APP讯，仙琚制药(002332.SZ)发布公告，公司于近日收到国家药品监督管理局下发的甲磺酸倍他司汀片境内生产药品注册受理通知书。 据悉，甲磺酸倍他司汀片，规格为6mg，参比制剂为原研的上市药品，其持证商为卫材(中国)药业有限公司，其英文名/商品名为Betahistine Mesilate Tablets/敏使朗。甲磺酸倍他司汀片最早由日本Eisai Co.,Ltd.研发，商品名为Mer ...

Its product portfolio includes tafluprost/timolol maleate, a prostaglandin F2a derivative and a beta-adrenergic receptor blocker; and netarsudil mesilate and latanoprost, a prostaglandin F2a ...

4307.T Nomura Research Institute, Ltd.

Laboratory for the Research of the Mechanisms of Regulation and Compensation of Nervous System Excitability Pathologies, I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry RAS, Saint ...

Accident and Emergency Department, Birmingham, Children’s Hospital, Birmingham, UK Correspondence to: Dr I Velissariou Accident and Emergency, Department, Birmingham Children’s Hospital, Steelhouse, ...